Cardiol Therapeutics Inc. (CRDL)

NASDAQ: CRDL · IEX Real-Time Price · USD

1.980

0.00 (0.00%)

At close: May 3, 2024, 4:00 PM

2.000

+0.020 (1.01%)

After-hours: May 3, 2024, 7:22 PM EDT

Cardiol Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-28.13	-30.93	-31.64	-20.64	-13.68
Depreciation & Amortization	0.25	0.22	0.22	0.23	0.15
Share-Based Compensation	4.16	5.01	8.5	2.77	3.27
Other Operating Activities	-1.46	-1.52	-0.62	8.52	-1.11
Operating Cash Flow	-25.18	-27.22	-23.54	-9.13	-11.38
Capital Expenditures	-0.06	-0.07	-0.01	-0.04	-0.42
Investing Cash Flow	-0.06	-0.07	-0.01	-0.04	-0.42
Share Issuance / Repurchase	0	0	98.72	17.43	2.05
Debt Issued / Paid	-0.06	-0.05	-0.05	-0.05	-0.02
Other Financing Activities	-	-	-5.23	-1.09	-
Financing Cash Flow	-0.06	-0.05	93.44	16.3	2.03
Exchange Rate Effect	0.76	2.92	-0.01	-0.06	0
Net Cash Flow	-25.3	-27.35	69.89	7.13	-9.78
Free Cash Flow	-25.24	-27.3	-23.55	-9.17	-11.8
Free Cash Flow Margin	-	-	-29904.22%	-	-
Free Cash Flow Per Share	-0.39	-0.44	-0.55	-0.31	-0.46

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).